PATH Malaria Vaccine Initiative Announces Partnership To Develop Novel Malaria Vaccine

Thu, 21 Dec 2006 09:00 AM EST

... In a move that promises to expand the types of malaria vaccine candidates in clinical development, the PATH Malaria Vaccine Initiative (MVI) has announced a new partnership with Sanaria Inc., a Maryland company, to accelerate development of a unique malaria vaccine candidate.Supported by a $29. [click link for full article] ...